It is recommended that these medications be stored in a cool, dry place away from direct sunlight and moisture
In addition, when assessing the hazard ratios for MACE (and its components) for semaglutide vs comparators across the quartiles of CV risk, no significant interactions between treatment effect and baseline CV risk quartiles were found (Additional file 6: Appendix Figure S1)
However, it is best to avoid prolonged exposure to water or intense heat
Most common side effects (12mg dose, across TRIUMPH-4 and TRIUMPH-1): Nausea: 43% TRIUMPH-4 / ~38% TRIUMPH-1 (mostly during dose escalation) Diarrhea: 33% / ~28% (peaks weeks 48, improves by week 16) Dysesthesia: 20.9% (tingling sensations onset variable, long-term persistence unknown) Vomiting: 21% / ~25% (decreases after month 3) Constipation: 25% Discontinuation rates: 18.2% in TRIUMPH-4 (osteoarthritis population), 11.3% in TRIUMPH-1 (general obesity population)
A chemical reaction causes body odorit happens to every human being on the planet
Specific LIP-C dosing is set by a prescribing provider based on indication, individual factors, and tolerability
